查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
Dravet症候群的全球市场(2023年～2032年):市场占有率，规模，趋势，产业分析，各发作类型，诊断，各重症度，各治疗法，各最终用途，各流通管道，各地区，市场区隔预测
市场调查报告书
商品编码
1238770

Dravet症候群的全球市场(2023年～2032年):市场占有率，规模，趋势，产业分析，各发作类型，诊断，各重症度，各治疗法，各最终用途，各流通管道，各地区，市场区隔预测

Dravet Syndrome Market Share, Size, Trends, Industry Analysis Report, By Type of Seizures ; By Diagnosis; By Severity; By Treatment; By End-Use; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 126 Pages | 商品交期: 最快1-2个工作天内

价格

全球Dravet症候群的市场规模，预计至2032年达到5亿5,717万美元。

本报告提供全球Dravet症候群市场调查，市场概要，市场的推动因素与阻碍因素的分析，市场机会，COVID-19影响，各市场区隔的市场分析，竞争情形，主要企业的简介等系统性资讯。

目录

第1章 简介

  • 关于报告
    • 调查目的
    • 市场范围
    • 前提条件
  • 利害关係者

第2章 摘要整理

  • 市场概况

第3章 调查手法

  • 概要
    • 资料探勘
  • 资料资讯来源
    • 一级资讯来源
    • 二级资讯来源

第4章 全球Dravet症候群市场:洞察

  • 产业的概述
  • 市场动态
    • 促进因素和机会
    • 阻碍因素与课题
  • 波特的五力分析
    • 供给企业谈判力(中)
    • 新加入厂商的威胁(低)
    • 买方议价能力(中)
    • 替代威胁(中)
    • 现有企业间的竞争(高)
  • 大环境分析
  • 产业趋势
  • COVID-19影响分析

第5章 全球Dravet症候群市场:各诊断

  • 主要调查结果
  • 简介
    • 各诊断的全球市场(2019年～2032年)
  • MRI
    • MRI，各地区(2019年～2032年)
  • ECG
    • ECG，各地区(2019年～2032年)
  • SCN1A试验
    • SCN1A试验，各地区(2019年～2032年)

第6章 全球Dravet症候群市场:各重症度

  • 主要调查结果
  • 简介
    • 各重症度的全球市场(2019年～2032年)
  • 小病
    • 小病，各地区(2019年～2032年)
  • 中等症
    • 中等症，各地区(2019年～2032年)
  • 重病
    • 重病，各地区(2019年～2032年)

第7章 全球Dravet症候群市场:各治疗法

  • 主要调查结果
  • 简介
    • 各治疗法的全球市场(2019年～2032年)
  • 发作
    • 发作，各地区(2019年～2032年)
  • 投药
    • 投药，各地区(2019年～2032年)
  • Clobazam
    • Clobazam，各地区(2019年～2032年)
  • Stiripentol
    • Stiripentol ，各地区(2019年～2032年)
  • 丙戊酸钠
    • 丙戊酸钠，各地区(2019年～2032年)
  • 其他
    • 其他，各地区(2019年～2032年)
  • Ketogenic diet
    • Ketogenic diet ，各地区(2019年～2032年)
  • 迷走神经刺激
    • 迷走神经刺激，各地区(2019年～2032年)

第8章 全球Dravet症候群市场:各流通管道

  • 主要调查结果
  • 简介
    • 各流通管道的全球市场(2019年～2032年)
  • 直接竞标
    • 直接竞标，各地区(2019年～2032年)
  • 医院药局
    • 医院药局，各地区(2019年～2032年)
  • 零售药局
    • 零售药局，各地区(2019年～2032年)
  • 其他
    • 其他，各地区(2019年～2032年)

第9章 全球Dravet症候群市场:各发作类型

  • 主要调查结果
  • 简介
    • 各发作类型的全球市场(2019年～2032年)
  • 肌阵挛发作
    • 肌阵挛发作，各地区(2019年～2032年)
  • 失张力发作
    • 失张力发作，各地区(2019年～2032年)
  • 部分性发作
    • 部分性发作，各地区(2019年～2032年)
  • 强直阵挛发作
    • 强直阵挛发作，各地区(2019年～2032年)
  • 光敏性发作
    • 光敏性发作，各地区(2019年～2032年)
  • 其他
    • 其他，各地区(2019年～2032年)

第10章 全球Dravet症候群市场:各最终用途

  • 主要调查结果
  • 简介
    • 各最终用途全球市场(2019年～2032年)
  • 製药企业
    • 製药企业，各地区(2019年～2032年)
  • 医院
    • 医院，各地区(2019年～2032年)
  • 诊断检验室
    • 诊断检验室，各地区(2019年～2032年)
  • 学术研究机关
    • 学术研究机关，各地区(2019年～2032年)
  • 其他
    • 其他，各地区(2019年～2032年)

第11章 全球Dravet症候群市场:各地区

  • 主要调查结果
  • 简介
    • Dravet症候群市场评估:地区(2019年～2032年)
  • 北美
    • 诊断
    • 各流通管道
    • 各重症度
    • 各发作类型
    • 各治疗法
    • 各最终用途
    • 美国
    • 加拿大
  • 欧洲
    • 诊断
    • 各流通管道
    • 各重症度
    • 各发作类型
    • 各治疗法
    • 各最终用途
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 诊断
    • 各流通管道
    • 各重症度
    • 各发作类型
    • 各治疗法
    • 各最终用途
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 印尼
    • 韩国
  • 中东、非洲
    • 诊断
    • 各流通管道
    • 各重症度
    • 各发作类型
    • 各治疗法
    • 各最终用途
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
  • 南美
    • 诊断
    • 各流通管道
    • 各重症度
    • 各发作类型
    • 各治疗法
    • 各最终用途
    • 墨西哥
    • 巴西
    • 阿根廷

第12章 竞争情形

  • 扩大和收购的分析
    • 扩张
    • 收购
  • 伙伴关係/合作/协定/展示会

第13章 企业简介

  • Biscayne Neurotherapeutics
  • Epygenix Therapeutics
  • OPKO Health
  • GW Pharmaceuticals
  • Ovid Therapeutics
  • PTC Therapeutics
  • Sage Therapeutics
  • INSYS Therapeutics
  • Takeda Pharmaceutical
  • ThermoFisher Life
  • Xenon Pharmaceutical
  • Zogenix Inc.
Product Code: PM3033

The global dravet syndrome market size is expected to reach USD 557.17 million by 2032, according to a new study by Polaris Market Research. The report "Dravet Syndrome Market Share, Size, Trends, Industry Analysis Report, By Type of seizures (Myoclonic seizures, Atonic seizures, Partial seizures, Tonic-clonic seizures, photosensitive seizures Others); By Diagnosis; By Severity; By Treatment; By End-Use; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market's revenue growth will most likely be driven by enhanced genetic testing, which has increased the probability of Dravet syndrome diagnosis. An increase in improved regulatory environment for the healthcare sector and government funding for R&D has contributed to growth in the revenue of market. Improved healthcare infrastructure and greater healthcare budgets are expected to promote market revenue growth during the projected period. Increasing R&D initiatives for the discovery of innovative medications for syndrome are projected to drive growth in the future.

The U.S. FDA authorized the approval of the Diacomit in August 2020, for treating seizures linked with Dravet syndrome. Drug market share is expected to expand significantly after 2020 as a result of improved efficiency, safety, & longer seizure relief. Dravet syndrome is an exceedingly unusual neurological disorder that is typically lifelong. According to the Dravet Foundation, 1 in every 15,700 newborns born in the United States has Dravet syndrome.

Encoded's precision gene therapy seeks to treat gait issues, ataxia (poor coordination), and developmental delays. It is intended to treat mutations in the SCN1A gene, which are the cause of the majority of Dravet cases, by increasing endogenous SCN1A expression in a particular cell type in the brain. The therapy increased SCN1A expression in a subset of inhibitory interneurons. Encoded intends to begin clinical trials for the therapy in early 2021. As numerous rich nations face a failure of these specifics, the increased demand for COVID-19 operation curatives has created enormous eventualities for manufacturers. Because of the need for vaccinations and treatment specifics for COVID-19, biopharma assiduity is likely to increase significantly in future. This, in turn, is projected to have a major influence on the dravet syndrome market as an effect of COVID-19.

Dravet Syndrome Market Report Highlights:

  • Myoclonic Seizures held the largest revenue share as it affects both sides of the brain simultaneously. It is widely used for children with Dravet syndrome and other epileptic conditions.
  • The hospital pharmacies lead the market segment because of the availability and accessibility of innovative therapies and equipment.
  • The global players include: Biscayne, Cyberonics, INSYS Therapeutics, Epygenix Therapeutics, GW Pharmaceuticals, Ovid Therapeutics, PTC Therapeutics, Sage Therapeutics, Takeda Pharmaceutical, ThermoFisher Life, OPKO Health, Xenon Pharmaceutical, and Zogenix.

Polaris Market Research has segmented the Dravet syndrome market report based on form type of seizures, diagnosis, severity, treatment, end-use, distribution channel, and region:

Dravet Syndrome, Type of seizures Outlook (Revenue - USD Million, 2019 - 2032)

  • Myoclonic Seizures
  • Atonic Seizures
  • Partial Seizures
  • Tonic-Clonic Seizures
  • Photosensitive seizures
  • Others

Dravet Syndrome, Diagnosis Outlook (Revenue - USD Million, 2019 - 2032)

  • MRI
  • EEG
  • SCN1A testing

Dravet Syndrome, Severity Outlook (Revenue - USD Million, 2019 - 2032)

  • Mild
  • Moderate
  • Severe

Dravet Syndrome, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Seizure Medication
  • Clobazam
  • Stiripentol
  • Sodium Valproate
  • Others
  • Ketogenic Diet
  • Vagus Nerve Stimulation

Dravet Syndrome, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical companies
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutions
  • Others

Dravet Syndrome, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Direct tender
  • Hospital pharmacy
  • Retail Pharmacy
  • Others

Dravet Syndrome, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dravet Syndrome Market Insights

  • 4.1. Dravet Syndrome - Industry Snapshot
  • 4.2. Dravet Syndrome Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased government investment in R&D
      • 4.2.1.2. Availability of favorable reimbursement policies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Drug-related adverse effects and the high cost of existing treatments.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Dravet Syndrome Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Dravet Syndrome Market, by Diagnosis

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
  • 5.3. MRI
    • 5.3.1. Global Dravet Syndrome Market, by MRI, by Region, 2019-2032 (USD Million)
  • 5.4. ECG
    • 5.4.1. Global Dravet Syndrome Market, by ECG, by Region, 2019-2032 (USD Million)
  • 5.5. SCN1A testing
    • 5.5.1. Global Dravet Syndrome Market, by SCN1A testing, by Region, 2019-2032 (USD Million)

6. Global Dravet Syndrome Market, by Severity

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
  • 6.3. Mild
    • 6.3.1. Global Dravet Syndrome Market, by Mild, by Region, 2019-2032 (USD Million)
  • 6.4. Moderate
    • 6.4.1. Global Dravet Syndrome Market, by Moderate, by Region, 2019-2032 (USD Million)
  • 6.5. Severe
    • 6.5.1. Global Dravet Syndrome Market, by Severe, by Region, 2019-2032 (USD Million)

7. Global Dravet Syndrome Market, by Treatment

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • 7.3. Seizure
    • 7.3.1. Global Dravet Syndrome Market, by Seizure, by Region, 2019-2032 (USD Million)
  • 7.4. Medication
    • 7.4.1. Global Dravet Syndrome Market, by Medication, by Region, 2019-2032 (USD Million)
  • 7.5. Clobazam
    • 7.5.1. Global Dravet Syndrome Market, by Clobazam, by Region, 2019-2032 (USD Million)
  • 7.6. Stiripentol
    • 7.6.1. Global Dravet Syndrome Market, by Stiripentol, by Region, 2019-2032 (USD Million)
  • 7.7. Sodium Valproate
    • 7.7.1. Global Other Dravet Syndrome Market, by Sodium Valproate, by Region, 2019-2032 (USD Million)
  • 7.8. Others
    • 7.8.1. Global Other Dravet Syndrome Market, by Others, by Region, 2019-2032 (USD Million)
  • 7.9. Ketogenic diet
    • 7.9.1. Global Other Dravet Syndrome Market, by Ketogenic diet, by Region, 2019-2032 (USD Million)
  • 7.10. Vagus Nerve stimulation
    • 7.10.1. Global Other Dravet Syndrome Market, by Vagus Nerve stimulation, by Region, 2019-2032 (USD Million)

8. Global Dravet Syndrome Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.3. Direct Tender
    • 8.3.1. Global Dravet Syndrome Market, by Direct Tender, by Region, 2019-2032 (USD Million)
  • 8.4. Hospital pharmacy
    • 8.4.1. Global Dravet Syndrome Market, by Hospital pharmacy, by Region, 2019-2032 (USD Million)
  • 8.5. Retail Pharmacy
    • 8.5.1. Global Dravet Syndrome Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Dravet Syndrome Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Dravet Syndrome Market, by Type of seizures

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
  • 9.3. Myoclonic Seizures
    • 9.3.1. Global Dravet Syndrome Market, by Myoclonic Seizures, by Region, 2019-2032 (USD Million)
  • 9.4. Atonic Seizures
    • 9.4.1. Global Dravet Syndrome Market, by Atonic Seizures, by Region, 2019-2032 (USD Million)
  • 9.5. Partial Seizures
    • 9.5.1. Global Dravet Syndrome Market, by Partial Seizures, by Region, 2019-2032 (USD Million)
  • 9.6. Tonic-Clonic Seizures
    • 9.6.1. Global Dravet Syndrome Market, by Tonic-Clonic Seizures, by Region, 2019-2032 (USD Million)
  • 9.7. Photosensitive seizures
    • 9.7.1. Global Dravet Syndrome Market, by Photosensitive seizures, by Region, 2019-2032 (USD Million)
  • 9.8. Others
    • 9.8.1. Global Dravet Syndrome Market, by Others, by Region, 2019-2032 (USD Million)

10. Global Dravet Syndrome Market, by End-Use

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 10.3. Pharma companies
    • 10.3.1. Global Dravet Syndrome Market, by Pharma companies, by Region, 2019-2032 (USD Million)
  • 10.4. Hospitals
    • 10.4.1. Global Dravet Syndrome Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 10.5. Diagnostic Laboratories
    • 10.5.1. Global Dravet Syndrome Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)
  • 10.6. Academic and Research Institutes
    • 10.6.1. Global Dravet Syndrome Market, by Academic and Research Institutes, by Region, 2019-2032 (USD Million)
  • 10.7. Others
    • 10.7.1. Global Other End-Uses Dravet Syndrome Market, by Region, 2019-2032 (USD Million)

11. Global Dravet Syndrome Market, by Geography

  • 11.1. Key findings
  • 11.2. Introduction
    • 11.2.1. Dravet Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • 11.3. Dravet Syndrome Market - North America
    • 11.3.1. North America: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
    • 11.3.2. North America: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
    • 11.3.3. North America: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
    • 11.3.4. North America: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
    • 11.3.5. North America: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 11.3.6. North America: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.3.7. Dravet Syndrome Market - U.S.
      • 11.3.7.1. U.S.: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.3.7.2. U.S.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.3.7.3. U.S.: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.3.7.4. U.S.: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.3.7.5. U.S.: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.3.7.6. U.S.: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.3.8. Dravet Syndrome Market - Canada
      • 11.3.8.1. Canada: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.3.8.2. Canada.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.3.8.3. Canada: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.3.8.4. Canada: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.3.8.5. Canada: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.3.8.6. Canada: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 11.4. Dravet Syndrome Market - Europe
    • 11.4.1. Europe: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
    • 11.4.2. Europe.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
    • 11.4.3. Europe: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
    • 11.4.4. Europe: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
    • 11.4.5. Europe: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 11.4.6. Europe: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.7. Dravet Syndrome Market - UK
      • 11.4.7.1. UK: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.7.2. UK.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.7.3. UK: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.7.4. UK: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.7.5. UK: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.7.6. UK: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.8. Dravet Syndrome Market - France
      • 11.4.8.1. France: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.8.2. France.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.8.3. France: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.8.4. France: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.8.5. France: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.8.6. France: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.9. Dravet Syndrome Market - Germany
      • 11.4.9.1. Germany: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.9.2. Germany.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.9.3. Germany: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.9.4. Germany: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.9.5. Germany: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.9.6. Germany: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.10. Dravet Syndrome Market - Italy
      • 11.4.10.1. Italy: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.10.2. Italy.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.10.3. Italy: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.10.4. Italy: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.10.5. Italy: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.10.6. Italy: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.11. Dravet Syndrome Market - Spain
      • 11.4.11.1. Spain: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.11.2. Spain.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.11.3. Spain: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.11.4. Spain: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.11.5. Spain: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.11.6. Spain: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.12. Dravet Syndrome Market - Netherlands
      • 11.4.12.1. Netherlands: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.12.2. Netherlands.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.12.3. Netherlands: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.12.4. Netherlands: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.12.5. Netherlands: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.12.6. Netherlands: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.4.13. Dravet Syndrome Market - Russia
      • 11.4.13.1. Russia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.4.13.2. Russia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.4.13.3. Russia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.4.13.4. Russia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.4.13.5. Russia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.4.13.6. Russia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 11.5. Dravet Syndrome Market - Asia Pacific
    • 11.5.1. Asia Pacific: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
    • 11.5.2. Asia Pacific.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
    • 11.5.3. Asia Pacific: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
    • 11.5.4. Asia Pacific: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
    • 11.5.5. Asia Pacific: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 11.5.6. Asia Pacific: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.7. Dravet Syndrome Market - China
      • 11.5.7.1. China: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.7.2. China.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.7.3. China: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.7.4. China: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.7.5. China: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.7.6. China: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.8. Dravet Syndrome Market - India
      • 11.5.8.1. India: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.8.2. India.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.8.3. India: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.8.4. India: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.8.5. India: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.8.6. India: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.9. Dravet Syndrome Market - Japan
      • 11.5.9.1. Japan: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.9.2. Japan.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.9.3. Japan: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.9.4. Japan: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.9.5. Japan: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.9.6. Japan: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.10. Dravet Syndrome Market - Malaysia
      • 11.5.10.1. Malaysia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.10.2. Malaysia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.10.3. Malaysia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.10.4. Malaysia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.10.5. Malaysia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.10.6. Malaysia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.11. Dravet Syndrome Market - Indonesia
      • 11.5.11.1. Indonesia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.11.2. Indonesia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.11.3. Indonesia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.11.4. Indonesia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.11.5. Indonesia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.11.6. Indonesia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.5.12. Dravet Syndrome Market - South Korea
      • 11.5.12.1. South Korea: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.5.12.2. South Korea.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.5.12.3. South Korea: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.5.12.4. South Korea: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.5.12.5. South Korea: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.5.12.6. South Korea: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 11.6. Dravet Syndrome Market - Middle East & Africa
    • 11.6.1. Middle East & Africa: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
    • 11.6.2. Middle East & Africa: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
    • 11.6.3. Middle East & Africa: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
    • 11.6.4. Middle East & Africa: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
    • 11.6.5. Middle East & Africa: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 11.6.6. Middle East & Africa: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.6.7. Dravet Syndrome Market - Saudi Arabia
      • 11.6.7.1. Saudi Arabia: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.6.7.2. Saudi Arabia.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.6.7.3. Saudi Arabia: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.6.7.4. Saudi Arabia: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.6.7.5. Saudi Arabia: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.6.7.6. Saudi Arabia: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.6.8. Dravet Syndrome Market - UAE
      • 11.6.8.1. UAE: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.6.8.2. UAE.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.6.8.3. UAE: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.6.8.4. UAE: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.6.8.5. UAE: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.6.8.6. UAE: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.6.9. Dravet Syndrome Market - Israel
      • 11.6.9.1. Israel: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.6.9.2. Israel.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.6.9.3. Israel: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.6.9.4. Israel: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.6.9.5. Israel: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.6.9.6. Israel: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.6.10. Dravet Syndrome Market - South Africa
      • 11.6.10.1. South Africa: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.6.10.2. South Africa.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.6.10.3. South Africa: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.6.10.4. South Africa: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.6.10.5. South Africa: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.6.10.6. South Africa: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 11.7. Dravet Syndrome Market - Latin America
    • 11.7.1. Latin America: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
    • 11.7.2. Latin America.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
    • 11.7.3. Latin America: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
    • 11.7.4. Latin America: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
    • 11.7.5. Latin America: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 11.7.6. Latin America: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.7.7. Dravet Syndrome Market - Mexico
      • 11.7.7.1. Mexico: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.7.7.2. Mexico.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.7.7.3. Mexico: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.7.7.4. Mexico: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.7.7.5. Mexico: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.7.7.6. Mexico: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.7.8. Dravet Syndrome Market - Brazil
      • 11.7.8.1. Brazil: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.7.8.2. Brazil.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.7.8.3. Brazil: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.7.8.4. Brazil: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.7.8.5. Brazil: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.7.8.6. Brazil: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 11.7.9. Dravet Syndrome Market - Argentina
      • 11.7.9.1. Argentina: Dravet Syndrome Market, by Diagnosis, 2019-2032 (USD Million)
      • 11.7.9.2. Argentina.: Dravet Syndrome Market, by Distribution Channel, 2019-2032 (USD Million)
      • 11.7.9.3. Argentina: Dravet Syndrome Market, by Severity, 2019-2032 (USD Million)
      • 11.7.9.4. Argentina: Dravet Syndrome Market, by Type of seizures, 2019-2032 (USD Million)
      • 11.7.9.5. Argentina: Dravet Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 11.7.9.6. Argentina: Dravet Syndrome Market, by End-Use, 2019-2032 (USD Million)

12. Competitive Landscape

  • 12.1. Expansion and Acquisition Analysis
    • 12.1.1. Expansion
    • 12.1.2. Acquisitions
  • 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

  • 13.1. Biscayne Neurotherapeutics
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Benchmarking
    • 13.1.4. Recent Development
  • 13.2. Epygenix Therapeutics
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Benchmarking
    • 13.2.4. Recent Development
  • 13.3. OPKO Health
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Benchmarking
    • 13.3.4. Recent Development
  • 13.4. GW Pharmaceuticals
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Benchmarking
    • 13.4.4. Recent Development
  • 13.5. Ovid Therapeutics
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Benchmarking
    • 13.5.4. Recent Development
  • 13.6. PTC Therapeutics
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Benchmarking
    • 13.6.4. Recent Development
  • 13.7. Sage Therapeutics
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Benchmarking
    • 13.7.4. Recent Development
  • 13.8. INSYS Therapeutics
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Benchmarking
    • 13.8.4. Recent Development
  • 13.9. Takeda Pharmaceutical
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Benchmarking
    • 13.9.4. Recent Development
  • 13.10. ThermoFisher Life
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Benchmarking
    • 13.10.4. Recent Development
  • 13.11. Xenon Pharmaceutical
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Benchmarking
    • 13.11.4. Recent Development
  • 13.12. Zogenix Inc.
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Benchmarking
    • 13.12.4. Recent Development

List of Tables

  • Table 1 Global Dravet Syndrome Market, by Diagnosis, by Region, 2019-2032 (USD Million)
  • Table 2 Global Dravet Syndrome Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
  • Table 3 Global Dravet Syndrome Market, by Severity, by Region, 2019-2032 (USD Million)
  • Table 4 Global Dravet Syndrome Market, by Type of seizures, by Region, 2019-2032 (USD Million)
  • Table 5 Global Dravet Syndrome Market, by Treatment, by Region, 2019-2032 (USD Million)
  • Table 6 Global Dravet Syndrome Market, by End-Use, by Region, 2019-2032 (USD Million)